Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
- Posted on May 26, 2026
- By CNBC
- 0 Views
- 1 min read
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
